Christine William Shaker Basanti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christine William Shaker Basanti has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Magd Ahmed Kotb
Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
5 shared publications - Hend Abd El Baky
Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, John R. Oishei Children’s Hospital , Buffalo, NY 14203 , USA
2 shared publications Inas E.M. Kamel
Department of Pediatrics National Research Center Cairo Egypt
2 shared publicationsSally T. Mostafa El Sorogy
Department of Pediatrics Public Mounira Hospital Cairo Egypt
2 shared publicationsAlaa F. Hamza
Wadi El Nil Hospital Pediatric Living‐Related Liver Transplantation Team Cairo Egypt
1 shared publicationDalia S. Mosallam
Pediatric Hepatology Unit, Faculty of Medicine, Department of Pediatrics Cairo University Cairo Egypt
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 13, 13-22
The Machine Learned Stethoscope Provides Accurate Operator Independent Diagnosis of Chest Disease
Introduction: Contemporary stethoscope has limitations in diagnosis of chest conditions, necessitating further imaging modalities. Methods: We created 2 diagnostic computer aided non-invasive machine-learning models to recognize chest sounds. Model A was interpreter independent based on hidden markov model and mel frequency cepstral coefficient (MFCC). Model B was based on MFCC, hidden markov model, and chest sound wave image interpreter dependent analysis (phonopulmonography (PPG)). Results: We studied 464 records of actual chest sounds belonging to 116 children diagnosed by clinicians and confirmed by other imaging diagnostic modalities. Model A had 96.7% overall correct classification rate (CCR), 100% sensitivity and 100% specificity in discrimination between normal and abnormal sounds. CCR was 100% for normal vesicular sounds, crepitations 89.1%, wheezes 97.6%, and bronchial breathing 100%. Model B’s CCR was 100% for normal vesicular sounds, crepitations 97.3%, wheezes 97.6%, and bronchial breathing 100%. The overall CCR was 98.7%, sensitivity and specificity were 100%. Conclusion: Both models demonstrated very high precision in the diagnosis of chest conditions and in differentiating normal from abnormal chest sounds irrespective of operator expertise. Incorporation of computer-aided models in stethoscopes promises prompt, precise, accurate, cost-effective, non-invasive, operator independent, objective diagnosis of chest conditions and reduces number of unnecessary imaging studies.
- 1 January 2020
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. ume 13, 13-22
Open AccessThe Machine Learned Stethoscope Provides Accurate Operator Independent Diagnosis of Chest Disease
Introduction: Contemporary stethoscope has limitations in diagnosis of chest conditions, necessitating further imaging modalities. Methods: We created 2 diagnostic computer aided non-invasive machine-learning models to recognize chest sounds. Model A was interpreter independent based on hidden markov model and mel frequency cepstral coefficient (MFCC). Model B was based on MFCC, hidden markov model, and chest sound wave image interpreter dependent analysis (phonopulmonography (PPG)). Results: We studied 464 records of actual chest sounds belonging to 116 children diagnosed by clinicians and confirmed by other imaging diagnostic modalities. Model A had 96.7% overall correct classification rate (CCR), 100% sensitivity and 100% specificity in discrimination between normal and abnormal sounds. CCR was 100% for normal vesicular sounds, crepitations 89.1%, wheezes 97.6%, and bronchial breathing 100%. Model B’s CCR was 100% for normal vesicular sounds, crepitations 97.3%, wheezes 97.6%, and bronchial breathing 100%. The overall CCR was 98.7%, sensitivity and specificity were 100%. Conclusion: Both models demonstrated very high precision in the diagnosis of chest conditions and in differentiating normal from abnormal chest sounds irrespective of operator expertise. Incorporation of computer-aided models in stethoscopes promises prompt, precise, accurate, cost-effective, non-invasive, operator independent, objective diagnosis of chest conditions and reduces number of unnecessary imaging studies.
- Open Access
- 1 October 2019
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. ume 12, 401-408
Cholestasis In Infants With Down Syndrome Is Not Due To Extrahepatic Biliary Atresia: A Ten-Year Single Egyptian Centre Experience
Purpose: We aimed to define the clinical presentations, course and outcome of cholestasis in infants with Down syndrome (trisomy 21) who presented to the Pediatric Hepatology Clinic, New Children Hospital, Cairo University, Egypt. Methods: Retrospective analysis of data of cohort of infants with Down syndrome and cholestasis who followed up during 2005–2015. Results: Among 779 infants with cholestasis who presented during 2005–2015, 61 (7.8%) had Down syndrome. Six dropped out. Among the 55 who followed-up for a mean duration +SD = 12.1 ± 16.7 months, none had extrahepatic biliary atresia (EHBA), 37 (63.3%) had neonatal hepatitis and 18 (32.7%) had non-syndromic paucity of intrahepatic biliary radicals. Fourteen (25.4%) had associated congenital heart disease. Only 35 (63.3%) cleared the jaundice. Twenty-nine (52.7%) received ursodeoxycholic acid (UDCA); of them, 13 cleared the jaundice, one improved, 14 progressed and one died, compared to 22 who cleared the jaundice of the 26 who did not receive UDCA. Only three of those who did not receive UDCA progressed and none died. UDCA carried a 3.4-fold risk of poor prognosis (p= 0.001). UDCA use was associated with more complications (p= 0.016) in those with Down syndrome and cholestasis. Conclusion: We did not come across EHBA among neonates and infants with Down syndrome in 10 years. Non-syndromic paucity is associated with favorable outcome in infants with Down syndrome. UDCA use in cholestasis with Down syndrome is associated with poor outcome.
- 1 October 2019
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. ume 12, 401-408
Open AccessCholestasis In Infants With Down Syndrome Is Not Due To Extrahepatic Biliary Atresia: A Ten-Year Single Egyptian Centre Experience
Purpose: We aimed to define the clinical presentations, course and outcome of cholestasis in infants with Down syndrome (trisomy 21) who presented to the Pediatric Hepatology Clinic, New Children Hospital, Cairo University, Egypt. Methods: Retrospective analysis of data of cohort of infants with Down syndrome and cholestasis who followed up during 2005–2015. Results: Among 779 infants with cholestasis who presented during 2005–2015, 61 (7.8%) had Down syndrome. Six dropped out. Among the 55 who followed-up for a mean duration +SD = 12.1 ± 16.7 months, none had extrahepatic biliary atresia (EHBA), 37 (63.3%) had neonatal hepatitis and 18 (32.7%) had non-syndromic paucity of intrahepatic biliary radicals. Fourteen (25.4%) had associated congenital heart disease. Only 35 (63.3%) cleared the jaundice. Twenty-nine (52.7%) received ursodeoxycholic acid (UDCA); of them, 13 cleared the jaundice, one improved, 14 progressed and one died, compared to 22 who cleared the jaundice of the 26 who did not receive UDCA. Only three of those who did not receive UDCA progressed and none died. UDCA carried a 3.4-fold risk of poor prognosis (p= 0.001). UDCA use was associated with more complications (p= 0.016) in those with Down syndrome and cholestasis. Conclusion: We did not come across EHBA among neonates and infants with Down syndrome in 10 years. Non-syndromic paucity is associated with favorable outcome in infants with Down syndrome. UDCA use in cholestasis with Down syndrome is associated with poor outcome.
- 26 November 2018
- Published by Wiley in Pediatric Transplantation
- Vol. 23 (1) , e13313
Combined liver‐kidney transplantation for primary hyperoxaluria type I in children: Single Center Experience
Primary hyperoxalurias are rare inborn errors of metabolism with deficiency of hepatic enzymes that lead to excessive urinary oxalate excretion and overproduction of oxalate which is deposited in various organs. Hyperoxaluria results in serious morbid‐ity, end stage kidney disease (ESKD), and mortality if left untreated. Combined liver kidney transplantation (CLKT) is recognized as a management of ESKD for children with hyperoxaluria type 1 (PH1). This study aimed to report outcome of CLKT in a pediatric cohort of PH1 patients, through retrospective analysis of data of 8 children (2 girls and 6 boys) who presented by PH1 to Wadi El Nil Pediatric Living Related Liver Transplant Unit during 2001‐2017. Mean age at transplant was 8.2 ± 4 years. Only three of the children underwent confirmatory genotyping. Three patients died prior to surgery on waiting list. The first attempt at CLKT was consecutive, and despite initial successful liver transplant, the girl died of biliary peritonitis prior to scheduled renal transplant. Of the four who underwent simultaneous CLKT, only two survived and are well, one with insignificant complications, and other suffered from abdominal Burkitt lymphoma managed by excision and resection anastomosis, four cycles of rituximab, cyclophosphamide, vincristine, and prednisone. The other two died, one due to uncontrollable bleeding within 36 hours of procedure, while the other died awaiting renal transplant after loss of renal graft to recurrent renal oxalosis 6 months post‐transplant. PH1 with ESKD is a rare disease; simultaneous CLKT offers good quality of life for afflicted children. Graft shortage and renal graft loss to oxalosis challenge the outcome.
- 26 November 2018
- Published by Wiley in Pediatric Transplantation
- Vol. 23 (1) , e13313
Combined liver‐kidney transplantation for primary hyperoxaluria type I in children: Single Center Experience
Primary hyperoxalurias are rare inborn errors of metabolism with deficiency of hepatic enzymes that lead to excessive urinary oxalate excretion and overproduction of oxalate which is deposited in various organs. Hyperoxaluria results in serious morbid‐ity, end stage kidney disease (ESKD), and mortality if left untreated. Combined liver kidney transplantation (CLKT) is recognized as a management of ESKD for children with hyperoxaluria type 1 (PH1). This study aimed to report outcome of CLKT in a pediatric cohort of PH1 patients, through retrospective analysis of data of 8 children (2 girls and 6 boys) who presented by PH1 to Wadi El Nil Pediatric Living Related Liver Transplant Unit during 2001‐2017. Mean age at transplant was 8.2 ± 4 years. Only three of the children underwent confirmatory genotyping. Three patients died prior to surgery on waiting list. The first attempt at CLKT was consecutive, and despite initial successful liver transplant, the girl died of biliary peritonitis prior to scheduled renal transplant. Of the four who underwent simultaneous CLKT, only two survived and are well, one with insignificant complications, and other suffered from abdominal Burkitt lymphoma managed by excision and resection anastomosis, four cycles of rituximab, cyclophosphamide, vincristine, and prednisone. The other two died, one due to uncontrollable bleeding within 36 hours of procedure, while the other died awaiting renal transplant after loss of renal graft to recurrent renal oxalosis 6 months post‐transplant. PH1 with ESKD is a rare disease; simultaneous CLKT offers good quality of life for afflicted children. Graft shortage and renal graft loss to oxalosis challenge the outcome.
- 2 November 2018
- Published by Springer Nature
- p. 188-202
Recognition of Heart Murmur Based on Machine Learning and Visual Based Analysis of Phonocardiography
- 2 November 2018
- Published by Springer Nature
- p. 188-202
Recognition of Heart Murmur Based on Machine Learning and Visual Based Analysis of Phonocardiography
- Open Access
- 1 July 2018
- Published by Elsevier in Journal of Advanced Research
- Vol. 12, 39-45
Pilot study of classic galactosemia: Neurodevelopmental impact and other complications urge neonatal screening in Egypt
- 1 July 2018
- Published by Elsevier in Journal of Advanced Research
- Vol. 12, 39-45
Open AccessPilot study of classic galactosemia: Neurodevelopmental impact and other complications urge neonatal screening in Egypt
- Open Access
- 1 January 2016
- Published by The Science and Information Organization in International Journal of Advanced Computer Science and Applications
- Vol. 7 (7)
Improving the Recognition of Heart Murmur
Diagnosis of congenital cardiac defects is challenging, with some being diagnosed during pregnancy while others are diagnosed after birth or later on during childhood. Prompt diagnosis allows early intervention and best prognosis. Contemporary diagnosis relies upon the history, clinical examination, pulse oximetery, chest X-ray, electrocardiogram (ECG), echocardiography (ECHO), computed tomography (CT) and cardiac catheterization. These diagnostic modalities reliable upon recording electrical activity or sound waves or upon radiation. Yet, congenital heart diseases are still liable to misdiagnosis because of level of operator expertise and other multiple factors. In an attempt to minimize effect of operator expertise this paper built a classification model for heart murmur recognition using Hidden Markov Model (HMM). This paper used Mel Frequency Cepestral coefficient (MFCC) as a feature and 13 MFCC coefficients. The machine learning model built by studying 1069 different heart sounds covering normal heart sounds, ventricular septal defect (VSD), mitral regurgitation (MR), aortic stenosis (AS), aortic regurgitation (AR), patent ductus arteriosus (PDA), pulmonary regurgitation (PR), and pulmonary stenosis (PS). MFCC feature used to extract feature matrix for each type of heart sounds after separation according to amplitude threshold. The frequency of normal heart sound (range= 1Hz to 139Hz) was specific without overlap with any of the studied defects (ranged= 156-556Hz). The frequency ranges for each of these defects was typical without overlap according to examined heart area (aortic, pulmonary, tricuspid and mitral area). The overall correct classification rate (CCR) using this model was 96% and sensitivity 98%. This model has great potential for prompt screening and specific defect detection. Effect of cardiac contractility, cardiomegaly or cardiac electrical activity on this novel detection system needs to be verified in future works.
- 1 January 2016
- Published by The Science and Information Organization in International Journal of Advanced Computer Science and Applications
- Vol. 7 (7)
Open AccessImproving the Recognition of Heart Murmur
Diagnosis of congenital cardiac defects is challenging, with some being diagnosed during pregnancy while others are diagnosed after birth or later on during childhood. Prompt diagnosis allows early intervention and best prognosis. Contemporary diagnosis relies upon the history, clinical examination, pulse oximetery, chest X-ray, electrocardiogram (ECG), echocardiography (ECHO), computed tomography (CT) and cardiac catheterization. These diagnostic modalities reliable upon recording electrical activity or sound waves or upon radiation. Yet, congenital heart diseases are still liable to misdiagnosis because of level of operator expertise and other multiple factors. In an attempt to minimize effect of operator expertise this paper built a classification model for heart murmur recognition using Hidden Markov Model (HMM). This paper used Mel Frequency Cepestral coefficient (MFCC) as a feature and 13 MFCC coefficients. The machine learning model built by studying 1069 different heart sounds covering normal heart sounds, ventricular septal defect (VSD), mitral regurgitation (MR), aortic stenosis (AS), aortic regurgitation (AR), patent ductus arteriosus (PDA), pulmonary regurgitation (PR), and pulmonary stenosis (PS). MFCC feature used to extract feature matrix for each type of heart sounds after separation according to amplitude threshold. The frequency of normal heart sound (range= 1Hz to 139Hz) was specific without overlap with any of the studied defects (ranged= 156-556Hz). The frequency ranges for each of these defects was typical without overlap according to examined heart area (aortic, pulmonary, tricuspid and mitral area). The overall correct classification rate (CCR) using this model was 96% and sensitivity 98%. This model has great potential for prompt screening and specific defect detection. Effect of cardiac contractility, cardiomegaly or cardiac electrical activity on this novel detection system needs to be verified in future works.